Can Pediatrix Medical Group cover its short-term obligations?

Its current ratio is 1.33 — current assets exceed current liabilities.

Where does Pediatrix Medical Group's balance sheet data come from?

Every line is extracted from Pediatrix Medical Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Pediatrix Medical Group MD Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$205.78M+108%	$375.24M+63.2%	$340.06M+228%	$224.73M+1,058%	$98.98M+1,138%
Short-term investments	$123.19M+2.5%	$124.48M+5.0%	$123.04M+5.5%	$123.59M+8.6%	$120.2M+11.8%
Accounts receivable, net	$224.8M-7.3%	$229.67M-11.7%	$231.12M-84.3%	$238.99M-84.0%	$242.53M-83.4%
Prepaid expenses and other current assets	$12.87M+6.5%	$12.61M-6.0%	$8.94M-12.2%	$10.42M-12.5%	$12.09M-3.6%
Income taxes receivable	$12.19M+18.7%	$12.64M+0.2%	$3.82M+218%	$7.63M—	$10.27M—
Total current assets	$587.03M+19.4%	$763.51M+19.4%	$717.2M+35.8%	$613.05M+42.8%	$491.67M+15.3%
Property and equipment, net	$41.09M+7.5%	$39.18M0.0%	$38.64M-7.8%	$38.94M-18.7%	$38.22M-48.6%
Goodwill	$1.27B+2.1%	$1.26B+1.5%	$1.26B+1.3%	$1.24B+0.3%	$1.24B-10.8%
Intangible assets, net	$15.94M+53.4%	$16.86M+45.4%	$14.8M+12.3%	$9.3M-8.8%	$10.39M-44.6%
Deferred tax assets	$57M+65.6%	$57.02M+66.5%	$38.29M+7.5%	$36.02M+17.6%	$34.42M+0.9%
Other non-current assets	$55.4M-22.3%	$58.16M-24.1%	$57.89M-26.3%	$70.79M-11.0%	$71.35M-14.1%
Total assets	$2.07B+3.9%	$2.25B+4.4%	$2.2B+5.9%	$2.1B+5.3%	$1.99B-8.1%
Accounts payable	$31.54M-28.5%	$37.22M-19.8%	$38.65M-18.4%	$42.07M+31.5%	$44.12M+39.5%
Accrued expenses	$51.37M-11.2%	$51.31M-18.4%	$56.7M-1.4%	$57.57M+4.7%	$57.83M+7.0%
Accrued compensation	$92.77M+25.2%	$248.06M+15.2%	$183.31M+12.8%	$133.59M+16.1%	$74.1M+12.8%
Current portion of long-term debt	$192.42M+770%	$26.81M+30.5%	$25.34M+31.5%	$23.69M+33.6%	$22.13M+34.9%
Operating lease liabilities, current	$11.89M-2.4%	$11.59M-8.8%	$12.23M-28.0%	$12.05M-35.8%	$12.17M-42.1%
Income taxes payable	$1.4M-45.6%	$984K-54.7%	$2.75M-17.2%	$1.95M-69.2%	$2.58M-8.1%
Accrued interest	$2.78M-0.3%	$8.15M-0.1%	$2.78M-0.3%	$8.16M-1.2%	$2.78M-5.2%
Total current liabilities	$442.64M+63.3%	$458.91M+5.7%	$392.55M+5.2%	$341.04M+10.0%	$271.05M+9.6%
Long-term debt	$398.35M—	$570.53M—	$577.17M—	——	——
Operating lease liabilities, non-current	$27.06M-11.4%	$25.69M-19.6%	$27.53M-31.1%	$29.96M-39.1%	$30.54M-36.2%
Finance Lease Liabilities (Total)	——	——	——	——	——
Finance lease liabilities	——	——	——	——	——
Other non-current liabilities	$29.72M-3.7%	$30.34M-7.8%	$33.53M+1.5%	$33.3M+5.6%	$30.86M-7.9%
Total liabilities	$1.19B-1.0%	$1.38B-0.5%	$1.31B-2.7%	$1.27B-1.6%	$1.2B-8.2%
Preferred stock	$0—	$0—	$0—	$0—	$0—
Common stock	200M-99.9%	200M+23,183%	200B+99,900%	200B+99,900%	200B+99,900%
Additional paid-in capital	$931.26M-8.4%	$947.57M-6.5%	$1.01B-0.5%	$1.02B+1.5%	$1.02B+1.3%
Retained earnings	-$53.58M+76.5%	-$83.15M+66.5%	-$116.84M+58.1%	-$188.54M+36.8%	-$227.8M-56.6%
Accumulated other comprehensive income (loss)	$77K+126%	$610K+157%	$446K+313%	$137K+107%	-$292K+86.4%
Total stockholders' equity	$878.58M+11.3%	$865.85M+13.2%	$890.67M+21.6%	$833.75M+18.0%	$789.19M-7.8%
Total liabilities and stockholders' equity	$2.07B+3.9%	$2.25B+4.4%	$2.2B+5.9%	$2.1B+5.3%	$1.99B-8.1%
Total Cash, Cash Equivalents, and Restricted Cash (Inclusive)	$205.78M+108%	$375.24M+63.2%	$340.06M+228%	$224.73M+1,058%	$98.98M+1,138%
Cash, Cash Equivalents, and Marketable Securities	$123.19M+2.5%	$124.48M+5.0%	$123.04M+5.5%	$123.59M+8.6%	$120.2M+11.8%
Available For Sale Securities Debt Securities Current	$123.19M+2.5%	$124.48M+5.0%	$123.04M+5.5%	$123.59M+8.6%	$120.2M+11.8%
Other current assets	$8.21M+7.8%	$8.88M+74.5%	$10.22M+7.8%	$7.68M-22.8%	$7.61M-20.6%
Deferred Tax Assets and Other Non-Current Assets	$55.4M-22.3%	$58.16M-24.1%	$57.89M-26.3%	$70.79M-11.0%	$71.35M-14.1%
Deferred tax assets	$65.71M-33.9%	$73.92M-28.8%	$79.76M-33.2%	$88.73M-28.5%	$99.38M-2.5%
Intangible assets — net	$15.94M+53.4%	$16.86M+45.4%	$14.8M+12.3%	$9.3M-8.8%	$10.39M-44.6%
Operating And Finance Lease Right Of Use Assets	$36.87M-7.5%	$34.33M-12.6%	$35.7M-36.9%	$38.69M-40.8%	$39.87M-43.3%
Other non-current assets	$55.4M-22.3%	$58.16M-24.1%	$57.89M-26.3%	$70.79M-11.0%	$71.35M-14.1%
Software and Technology Licenses, Net	$55.4M-22.3%	$58.16M-24.1%	$57.89M-26.3%	$70.79M-11.0%	$71.35M-14.1%
Tax Deductible Goodwill	——	——	——	——	——
Accounts payable and other current liabilities (Note 11)	$236.93M+1.2%	$419.53M+5.2%	$352.23M+5.6%	$303.36M+13.5%	$234.17M+13.1%
Accrued Income Taxes, Current	$1.4M-45.6%	$984K-54.7%	$2.75M-17.2%	$1.95M-69.2%	$2.58M-8.1%
Current Portion of Long-Term Debt and Finance Lease Obligations	$192.42M+770%	$26.81M+30.5%	$25.34M+31.5%	$23.69M+33.6%	$22.13M+34.9%
Debt Instrument Stated Interest Rate	——	——	——	——	——
Long-Term Debt and Finance Lease Obligations	$398.35M—	$570.53M—	$577.17M—	——	——
Total debt	$629.72M-3.9%	$638M-4.4%	$642.27M+743%	$649.56M+658%	$655.32M+668%
Common Stock Par Value Per Share	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Common Stock Shares Issued	82.1M-4.4%	83M-3.4%	85.8M0.0%	86.9M+1.3%	85.8M+2.1%
Convertible Preferred Stock Authorized Shares	1M-99.9%	1M-99.9%	1B+99,900%	1B+99,900%	1B+99,900%
Convertible Preferred Stock Issued Shares	0—	0—	0—	0—	0—
Additional paid-in capital	$931.26M-8.4%	$947.57M-6.5%	$1.01B-0.5%	$1.02B+1.5%	$1.02B+1.3%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$821K-4.3%	$830K-3.4%	$858K-0.1%	$869K+1.3%	$858K+2.1%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—	$0—
Preferred Stock Par Value Per Share	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Share Repurchase Authorization Limit	——	——	——	——	——
Share Repurchase Program - Amount Remaining	——	——	——	——	——
Accrued Payroll Taxes And Benefits Current	$24.49M-3.5%	$39.62M+11.8%	$41.28M+20.2%	$31.38M+11.9%	$25.38M+7.2%
Available for sale investments	$123.19M+2.5%	$124.48M+5.0%	$123.04M+5.5%	$123.59M+8.6%	$120.2M+11.8%
Business Combination Operating Lease Liabilities	——	——	——	——	——
Business Combination Operating Lease Right Of Use Assets	——	——	——	——	——
Purchased finite-lived intangible assets	——	——	——	——	——
Cash and cash equivalents, end of period	$205.78M+108%	$375.24M+63.2%	$340.06M+228%	$224.73M+1,058%	$98.98M+1,138%
Common stock, par value (in dollars per share)	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Common stock, shares authorized (in shares)	$200M-99.9%	$200M-99.9%	$200B+99,900%	$200B+99,900%	$200B+99,900%
Common stock, shares issued (in shares)	$82.06M-4.4%	$82.98M-3.4%	$85.83M0.0%	$86.85M+1.3%	$85.81M+2.1%
Common Stock, Shares, Outstanding	$82.06M-4.4%	$82.98M-3.4%	$85.83M0.0%	$86.85M+1.3%	$85.81M+2.1%
Deferred income taxes	$57M+65.6%	$57.02M+66.5%	$38.29M+7.5%	$36.02M+17.6%	$34.42M+0.9%
Income taxes receivable	$12.19M+18.7%	$12.64M+0.2%	$3.82M+218%	$7.63M—	$10.27M—
Long-Term Debt and Lease Obligation	$398.35M—	$570.53M—	$577.17M—	——	——
Less: current maturities	$192.42M+770%	$26.81M+30.5%	$25.34M+31.5%	$23.69M+33.6%	$22.13M+34.9%
Malpractice Loss Contingency Accrual Undiscounted Noncurrent	$236.95M-4.0%	$238.35M-7.4%	$239.68M-6.1%	$244.16M-4.2%	$246.94M-3.5%
Malpractice Loss Contingency Accrual Undiscounted Current	$33.99M+13.4%	$35.18M+15.6%	$29.52M+1.9%	$30.61M+5.7%	$29.97M+3.2%
Other accrued liabilities	$51.37M-11.2%	$51.31M-18.4%	$56.7M-1.4%	$57.57M+4.7%	$57.83M+7.0%
Preferred Stock, Par or Stated Value Per Share	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Preferred Stock, Shares Authorized	$1M-99.9%	$1M-99.9%	$1B+99,900%	$1B+99,900%	$1B+99,900%
Preferred Stock, Shares Issued	$0—	$0—	$0—	$0—	$0—
Prepaid expenses	$12.87M+6.5%	$12.61M-6.0%	$8.94M-12.2%	$10.42M-12.5%	$12.09M-3.6%
Purchase Price	——	——	——	——	——
Share Repurchase Program, Authorized, Amount	——	——	——	——	——
Share Repurchase Program, Remaining Authorized, Amount	——	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Can Pediatrix Medical Group cover its short-term obligations?: Its current ratio is 1.33 — current assets exceed current liabilities.
Where does Pediatrix Medical Group's balance sheet data come from?: Every line is extracted from Pediatrix Medical Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.